Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) EBIT Margin: 2016-2024

Historic EBIT Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -0.27%.

  • Organogenesis Holdings' EBIT Margin rose 832.00% to 13.74% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.80%, marking a year-over-year increase of 101.00%. This contributed to the annual value of -0.27% for FY2024, which is 316.00% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' EBIT Margin is -0.27%, which was down 109.20% from 2.89% recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' EBIT Margin ranged from a high of 15.45% in FY2021 and a low of -0.27% during FY2024.
  • Over the past 3 years, Organogenesis Holdings' median EBIT Margin value was 2.89% (recorded in 2023), while the average stood at 2.52%.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 1,933bps in 2020, then tumbled by 1,051bps in 2022.
  • Yearly analysis of 5 years shows Organogenesis Holdings' EBIT Margin stood at 7.89% in 2020, then skyrocketed by 756bps to 15.45% in 2021, then tumbled by 1,051bps to 4.95% in 2022, then slumped by 205bps to 2.89% in 2023, then plummeted by 316bps to -0.27% in 2024.